DocSym
β
Searchsearch
Search
(N02.5) Recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
More details coming soon
415 686 in individuals diagnosis recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis confirmed
3 757 deaths with diagnosis recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
1% mortality rate associated with the disease recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
Diagnosis recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis is diagnosed Men are 20.32% more likely than Women
250 077
Men receive the diagnosis recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
2 465 (1.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
165 609
Women receive the diagnosis recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
1 292 (0.8 %)Died from this diagnosis.
Risk Group for the Disease recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis - Men aged 75-79 and Women aged 10-14
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
Absence or low individual and public risk
Recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis - what does this mean
Recurrent and persistent haematuria due to diffuse mesangiocapillary glomerulonephritis is caused by an autoimmune disorder in which the body's own immune system attacks the glomeruli, the filtering units of the kidneys. this leads to inflammation and damage, resulting in red blood cells being passed in the urine.
What happens during the disease - recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis
Recurrent and persistent haematuria is caused by diffuse mesangiocapillary glomerulonephritis, which is an autoimmune disorder in which the body's immune system mistakenly attacks the glomeruli, the tiny filters in the kidney that help remove waste from the blood. this attack causes inflammation and damage to the glomeruli, resulting in the leakage of red blood cells into the urine. this leakage causes the persistent and recurrent haematuria.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Urine analysis
- Blood tests, including complete blood count, electrolyte levels, and kidney function tests
- Imaging tests, such as X-ray, ultrasound, computerized tomography (CT) scan, and magnetic resonance imaging (MRI)
- Biopsy of the kidney
- Urine culture
- Renal scintigraphy
Treatment and Medical Assistance
Main goal of the treatment: Reduce the inflammation in the kidney and prevent further damage.
- Administer corticosteroids and immunosuppressants to reduce inflammation.
- Prescribe antibiotics to prevent and treat infections.
- Prescribe diuretics to reduce fluid retention.
- Monitor blood pressure and adjust medications accordingly.
- Monitor urine output and adjust medications accordingly.
- Monitor kidney function and adjust medications accordingly.
- Encourage a healthy lifestyle with a balanced diet and regular exercise.
- Provide emotional support and counselling.
9 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Recurrent and persistent haematuria : diffuse mesangiocapillary glomerulonephritis - Prevention
The prevention of recurrent and persistent haematuria due to diffuse mesangiocapillary glomerulonephritis is primarily achieved through the control of underlying conditions such as hypertension, diabetes, and immunological disorders. it is also important to avoid exposure to nephrotoxic agents such as certain medications, alcohol, and recreational drugs. early diagnosis and timely treatment of any underlying conditions is essential for preventing the progression of the disease.